Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.

Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ.

Pharmacoeconomics. 2019 Oct 21. doi: 10.1007/s40273-019-00848-8. [Epub ahead of print]

PMID:
31631254
2.

Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung Cancer.

Cohen JT, Lin PJ, Sheinson DM, Wong WB, Wu N, Yim YM, Ramsey SD.

J Oncol Pract. 2019 Nov;15(11):e948-e956. doi: 10.1200/JOP.19.00241. Epub 2019 Sep 12.

PMID:
31513478
3.

Novel Data Linkages to Characterize Palliative and End-Of-Life Care: Challenges and Considerations.

McDermott CL, Engelberg RA, Woo C, Li L, Fedorenko C, Ramsey SD, Curtis JR.

J Pain Symptom Manage. 2019 Nov;58(5):851-856. doi: 10.1016/j.jpainsymman.2019.07.017. Epub 2019 Jul 23.

PMID:
31349037
4.

Physician Ordering of Screening Ultrasound: National Rates and Association With State-Level Breast Density Reporting Laws.

Liao GJ, Hippe DS, Chen LE, Lee JM, Liao JM, Ramsey SD, Lee CI.

J Am Coll Radiol. 2019 Jul 18. pii: S1546-1440(19)30822-1. doi: 10.1016/j.jacr.2019.07.002. [Epub ahead of print]

PMID:
31326406
5.

Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.

Miles RC, Lee CI, Sun Q, Bansal A, Lyman GH, Specht JM, Fedorenko CR, Greenwood-Hickman MA, Ramsey SD, Lee JM.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):813-820. doi: 10.6004/jnccn.2018.7281.

PMID:
31319393
6.

Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA.

Steuten L, Garmo V, Phatak H, Sullivan SD, Nghiem P, Ramsey SD.

Appl Health Econ Health Policy. 2019 Oct;17(5):733-740. doi: 10.1007/s40258-019-00492-5.

7.

Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer.

Steuten L, Goulart B, Meropol NJ, Pritchard D, Ramsey SD.

JCO Clin Cancer Inform. 2019 Jun;3:1-10. doi: 10.1200/CCI.19.00002.

8.

Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources.

Ramsey SD, Shankaran V, Sullivan SD.

J Clin Oncol. 2019 Jun 24:JCO1802320. doi: 10.1200/JCO.18.02320. [Epub ahead of print] No abstract available.

PMID:
31233352
9.

Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.

Barger S, Sullivan SD, Bell-Brown A, Bott B, Ciccarella AM, Golenski J, Gorman M, Johnson J, Kreizenbeck K, Kurttila F, Mason G, Myers J, Seigel C, Wade JL 3rd, Walia G, Watabayashi K, Lyman GH, Ramsey SD.

BMC Med Res Methodol. 2019 Jun 11;19(1):119. doi: 10.1186/s12874-019-0764-2.

10.

Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.

Goulart BHL, Silgard ET, Baik CS, Bansal A, Sun Q, Durbin EB, Hands I, Shah D, Arnold SM, Ramsey SD, Kavuluru R, Schwartz SM.

JCO Clin Cancer Inform. 2019 May;3:1-15. doi: 10.1200/CCI.18.00098.

11.

Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure Models.

Bansal A, Sullivan SD, Lin VW, Purdum AG, Navale L, Cheng P, Ramsey SD.

Med Decis Making. 2019 Apr;39(3):294-298. doi: 10.1177/0272989X18820535. Epub 2019 Feb 28.

PMID:
30819038
12.

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL.

JAMA Oncol. 2019 Apr 1;5(4):497-505. doi: 10.1001/jamaoncol.2018.6437. Erratum in: JAMA Oncol. 2019 Mar 7;:.

PMID:
30653226
13.

Varroa destructor feeds primarily on honey bee fat body tissue and not hemolymph.

Ramsey SD, Ochoa R, Bauchan G, Gulbronson C, Mowery JD, Cohen A, Lim D, Joklik J, Cicero JM, Ellis JD, Hawthorne D, vanEngelsdorp D.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1792-1801. doi: 10.1073/pnas.1818371116. Epub 2019 Jan 15.

14.

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL.

JAMA Netw Open. 2018 Aug 3;1(4):e181235. doi: 10.1001/jamanetworkopen.2018.1235.

15.

Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes.

Jones SMW, Chennupati S, Nguyen T, Fedorenko C, Ramsey SD.

Medicine (Baltimore). 2019 Jan;98(1):e14004. doi: 10.1097/MD.0000000000014004.

16.

Reply.

Doll KM, Goff BA, Ramsey SD.

Am J Obstet Gynecol. 2019 Apr;220(4):409. doi: 10.1016/j.ajog.2018.12.036. Epub 2018 Dec 27. No abstract available.

PMID:
30594566
17.

Lessons From Reporting National Performance Measures in a Regional Setting: Washington State Community Cancer Care Report.

Panattoni L, Fedorenko C, Kreizenbeck K, Sun Q, Li L, Conklin T, Lyman GH, Ramsey SD.

J Oncol Pract. 2018 Dec;14(12):e801-e814. doi: 10.1200/JOP.18.00410.

PMID:
30537450
18.

The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations.

Panattoni L, Lieu TA, Jayasekera J, O'Neill S, Mandelblatt JS, Etzioni R, Phelps CE, Ramsey SD.

Breast Cancer Res Treat. 2019 Jan;173(2):417-427. doi: 10.1007/s10549-018-4988-3. Epub 2018 Oct 10.

PMID:
30306429
19.

Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.

Doll KM, Khor S, Odem-Davis K, He H, Wolff EM, Flum DR, Ramsey SD, Goff BA.

Am J Obstet Gynecol. 2018 Dec;219(6):593.e1-593.e14. doi: 10.1016/j.ajog.2018.09.040. Epub 2018 Oct 3.

PMID:
30291839
20.

What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?

Flowers CR, Ramsey SD.

J Clin Oncol. 2018 Oct 2:JCO2018793570. doi: 10.1200/JCO.2018.79.3570. [Epub ahead of print] No abstract available.

PMID:
30277825
21.

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States.

Roth JA, Sullivan SD, Lin VW, Bansal A, Purdum AG, Navale L, Cheng P, Ramsey SD.

J Med Econ. 2018 Dec;21(12):1238-1245. doi: 10.1080/13696998.2018.1529674. Epub 2018 Oct 16. Erratum in: J Med Econ. 2018 Dec;21(12):1255.

PMID:
30260711
22.

Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.

McDermott CL, Bansal A, Ramsey SD, Lyman GH, Sullivan SD.

J Pain Symptom Manage. 2018 Nov;56(5):699-708.e1. doi: 10.1016/j.jpainsymman.2018.08.004. Epub 2018 Aug 17.

23.

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.

Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD.

Cancer Med. 2018 Sep;7(9):4251-4260. doi: 10.1002/cam4.1657. Epub 2018 Jul 20.

24.

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.

Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM Jr, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL.

Cancer Epidemiol. 2018 Aug;55:117-122. doi: 10.1016/j.canep.2018.06.005. Epub 2018 Jun 21.

25.

A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.

Deverka PA, Bangs R, Kreizenbeck K, Delaney DM, Hershman DL, Blanke CD, Ramsey SD.

J Natl Cancer Inst. 2018 Jun 1;110(6):553-559. doi: 10.1093/jnci/djy064. Review.

26.

Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials.

Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, Unger JM.

J Clin Oncol. 2018 Sep 10;36(26):2710-2717. doi: 10.1200/JCO.2017.77.4414. Epub 2018 Mar 27.

27.

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Unger JM, Hershman DL, Till C, Tangen CM, Barlow WE, Ramsey SD, Goodman PJ, Thompson IM Jr.

J Natl Cancer Inst. 2018 Nov 1;110(11):1208-1215. doi: 10.1093/jnci/djy035.

28.

Indian Health Service Care System and Cancer Stage in American Indians and Alaska Natives.

Burnett-Hartman AN, Adams SV, Bansal A, McDougall JA, Cohen SA, Karnopp A, Warren-Mears V, Ramsey SD.

J Health Care Poor Underserved. 2018;29(1):245-252. doi: 10.1353/hpu.2018.0017.

PMID:
29503298
29.

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

Garrison LP Jr, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC.

Value Health. 2018 Feb;21(2):161-165. doi: 10.1016/j.jval.2017.12.009.

30.

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].

Willke RJ, Neumann PJ, Garrison LP Jr, Ramsey SD.

Value Health. 2018 Feb;21(2):155-160. doi: 10.1016/j.jval.2017.12.011.

31.

Characterizing Potentially Preventable Cancer- and Chronic Disease-Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study.

Panattoni L, Fedorenko C, Greenwood-Hickman MA, Kreizenbeck K, Walker JR, Martins R, Eaton KD, Rieke JW, Conklin T, Smith B, Lyman G, Ramsey SD.

J Oncol Pract. 2018 Mar;14(3):e176-e185. doi: 10.1200/JOP.2017.028191. Epub 2018 Feb 8.

PMID:
29452549
32.

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.

Chavez-MacGregor M, Unger JM, Moseley A, Ramsey SD, Hershman DL.

Cancer. 2018 Apr 15;124(8):1760-1769. doi: 10.1002/cncr.31241. Epub 2018 Jan 25.

33.

End-of-Life Services Among Patients With Cancer: Evidence From Cancer Registry Records Linked With Commercial Health Insurance Claims.

McDermott CL, Fedorenko C, Kreizenbeck K, Sun Q, Smith B, Curtis JR, Conklin T, Ramsey SD.

J Oncol Pract. 2017 Nov;13(11):e889-e899. doi: 10.1200/JOP.2017.021683. Epub 2017 Jul 19.

34.
35.

Insurance Coverage and Aid-in-Dying Medication Costs-Reply.

Shankaran V, LaFrance RJ, Ramsey SD.

JAMA Oncol. 2017 Aug 1;3(8):1138. doi: 10.1001/jamaoncol.2017.0406. No abstract available.

PMID:
28542690
36.

Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.

Roth JA, Goulart BH, Ravelo A, Kolkey H, Ramsey SD.

Oncologist. 2017 Mar;22(3):304-310. doi: 10.1634/theoncologist.2016-0253. Epub 2017 Feb 27.

37.

Cancer Treatment Delays in American Indians and Alaska Natives Enrolled in Medicare.

Adams SV, Bansal A, Burnett-Hartman AN, Cohen SA, Karnopp A, Warren-Mears V, Ramsey SD.

J Health Care Poor Underserved. 2017;28(1):350-361. doi: 10.1353/hpu.2017.0027.

PMID:
28239006
38.

Information Seeking and Satisfaction with Information Sources Among Spouses of Men with Newly Diagnosed Local-Stage Prostate Cancer.

Bansal A, Koepl LM, Fedorenko CR, Li C, Smith JL, Hall IJ, Penson DF, Ramsey SD.

J Cancer Educ. 2018 Apr;33(2):325-331. doi: 10.1007/s13187-017-1179-6.

39.

Evaluating Frameworks That Provide Value Measures for Health Care Interventions.

Mandelblatt JS, Ramsey SD, Lieu TA, Phelps CE.

Value Health. 2017 Feb;20(2):185-192. doi: 10.1016/j.jval.2016.11.013.

40.

Oncologist and organizational factors associated with variation in breast cancer multigene testing.

Lieu TA, Ray GT, Prausnitz SR, Habel LA, Alexeeff S, Li Y, Ramsey SD, Phelps CE, Chawla N, C O'Neill S, Mandelblatt JS.

Breast Cancer Res Treat. 2017 May;163(1):167-176. doi: 10.1007/s10549-017-4158-z. Epub 2017 Feb 21.

41.

Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.

Lee CI, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Jarvik JG, Lehman CD, Ramsey SD.

J Am Coll Radiol. 2016 Nov;13(11S):R81-R88. doi: 10.1016/j.jacr.2016.09.032.

PMID:
27814820
42.

Drug Price Inflation and the Cost of Assisted Death for Terminally Ill Patients-Death With Indignity.

Shankaran V, LaFrance RJ, Ramsey SD.

JAMA Oncol. 2017 Jan 1;3(1):15-16. doi: 10.1001/jamaoncol.2016.3842. No abstract available.

PMID:
27711921
43.

Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives.

Gries KS, Regier DA, Ramsey SD, Patrick DL.

Appl Health Econ Health Policy. 2017 Jun;15(3):375-384. doi: 10.1007/s40258-016-0282-x.

PMID:
27704390
44.

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.

Ramsey SD, Nademanee A, Masszi T, Holowiecki J, Abidi M, Chen A, Stiff P, Viviani S, Sweetenham JW, Radford J, Zhu Y, Bonthapally V, Thomas E, Richhariya A, Hunder NN, Walewski J, Moskowitz CH.

Br J Haematol. 2016 Dec;175(5):860-867. doi: 10.1111/bjh.14316. Epub 2016 Sep 21.

45.

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

Unger JM, Till C, Thompson IM Jr, Tangen CM, Goodman PJ, Wright JD, Barlow WE, Ramsey SD, Minasian LM, Hershman DL.

J Natl Cancer Inst. 2016 Aug 26;108(12). pii: djw168. doi: 10.1093/jnci/djw168. Print 2016 Dec.

46.

Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer.

Loggers ET, Buist DS, Gold LS, Zeliadt S, Hunter Merrill R, Etzioni R, Ramsey SD, Sullivan SD, Kessler L.

Int J Breast Cancer. 2016;2016:2182985. doi: 10.1155/2016/2182985. Epub 2016 Jul 25.

47.

Low Fuel Convergence Path to Direct-Drive Fusion Ignition.

Molvig K, Schmitt MJ, Albright BJ, Dodd ES, Hoffman NM, McCall GH, Ramsey SD.

Phys Rev Lett. 2016 Jun 24;116(25):255003. doi: 10.1103/PhysRevLett.116.255003. Epub 2016 Jun 24.

PMID:
27391731
48.

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.

Hershman DL, Till C, Wright JD, Awad D, Ramsey SD, Barlow WE, Minasian LM, Unger J.

J Clin Oncol. 2016 Sep 1;34(25):3014-22. doi: 10.1200/JCO.2015.66.2346. Epub 2016 Jun 20.

49.

Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure.

Bennette CS, Richards C, Sullivan SD, Ramsey SD.

Health Aff (Millwood). 2016 May 1;35(5):805-12. doi: 10.1377/hlthaff.2015.1145.

PMID:
27140986
50.

Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer.

Gries KS, Regier DA, Ramsey SD, Patrick DL.

Value Health. 2016 Mar-Apr;19(2):218-25. doi: 10.1016/j.jval.2015.11.012. Epub 2016 Jan 14.

Supplemental Content

Loading ...
Support Center